Canada markets open in 9 hours 10 minutes

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.32-0.90 (-2.04%)
At close: 04:00PM EDT
43.30 -0.02 (-0.05%)
After hours: 05:38PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-214,529
-214,529
-163,918
-107,641
-73,812
Depreciation & amortization
1,098
1,098
983
922
948
Stock based compensation
40,937
40,937
28,268
17,352
10,427
Change in working capital
8,044
8,044
18,612
1,096
376
Accounts receivable
14,648
14,648
10,994
6,293
2,723
Accounts Payable
-
-
-
6,293
2,723
Other working capital
-170,995
-170,995
-116,861
-89,024
-62,213
Other non-cash items
-790
-790
406
-739
261
Net cash provided by operating activites
-166,307
-166,307
-115,205
-88,588
-62,027
Cash flows from investing activities
Investments in property, plant and equipment
-4,688
-4,688
-1,656
-436
-186
Purchases of investments
-532,857
-532,857
-329,817
-125,404
-135,592
Sales/Maturities of investments
337,132
337,132
157,493
69,357
135,995
Net cash used for investing activites
-200,413
-200,413
-173,980
-56,483
217
Cash flows from financing activities
Debt repayment
0
-
-
-
-
Common stock issued
369,019
369,019
117,242
249,542
114,283
Common stock repurchased
-
-
-
0
0
Net cash used privided by (used for) financing activities
388,944
388,944
121,963
252,679
114,571
Net change in cash
22,224
22,224
-167,222
107,608
52,761
Cash at beginning of period
33,973
33,973
201,195
93,587
40,826
Cash at end of period
56,197
56,197
33,973
201,195
93,587
Free Cash Flow
Operating Cash Flow
-166,307
-166,307
-115,205
-88,588
-62,027
Capital Expenditure
-4,688
-4,688
-1,656
-436
-186
Free Cash Flow
-170,995
-170,995
-116,861
-89,024
-62,213